An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.
November 2022 EIPM Director's Memo
November 1, 2022
Dear Members of the Englander Institute,
I’m really happy to share this month’s EIPM Director’s Memo with you because there are so many great new initiatives, partnerships, news coverage, events, and publications to celebrate!
New Computational Method Builds Detailed Maps of Human Tissues
October 31, 2022
Weill Cornell Medicine researchers have developed a computational method to map the architecture of human tissues in unprecedented detail. Their approach promises to accelerate studies on organ-scale cellular interactions and could enable powerful new diagnostic strategies for a wide range of diseases.
EIPM Researchers find Corrupt Endothelial Cells Protect Blood Cancer Cells from Chemotherapy
October 17, 2022
Endothelial cells—the cells that line blood vessels—grown alongside leukemia cells become corrupted and rescue the cancer cells from many chemotherapy drugs, a study by Weill Cornell Medicine investigators found.
MCC and EIPM Wrap-Up Successful Summer Program
October 17, 2022
The Meyer Cancer Center (MCC) and Englander Institute for Precision Medicine (EIPM) recently wrapped up their annual 6-week summer program for approximately 50 high school juniors and seniors, and college students. Designed to improve education related to cancer and precision medicine, the hybrid summer program provides mentorship, and encourages the pursuit of STEM careers.
Gene Duo Protects Blood Vessel Health
October 6, 2022
Two genes working in concert sustain the integrity of healthy blood vessels, Weill Cornell Medicine investigators discovered in new research. The findings could lead to new approaches treating cardiovascular disease or other inflammatory conditions.
Autumn 2022 EIPM External Newsletter
October 4, 2022
Autumn 2022
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our third quarterly external newsletter of 2022!
Cross-campus initiative to accelerate innovations in engineering, medicine
September 29, 2022
Weill Cornell Medicine and Cornell Engineering are launching Engineering Innovations in Medicine, an initiative that will form unconventional partnerships that transcend academic disciplines to find solutions for such diseases as Alzheimer’s, cancer and diabetes.
Novel Technique Reveals Surprising New Way to Suppress Tumor Cells
September 27, 2022
By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it’s produced. The work, published Sept. 27 in Cell Reports, reveals a new aspect of tumor cell biology, and points to a promising strategy for treating many types of cancer.
Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry
September 19, 2022
Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer (TNBC). Their analysis of TNBC tumors from a diverse patient population yielded a large set of genes whose expression differed in patients with African ancestry compared with patients with European ancestry.